CMMB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Chemomab Therapeutics Ltd (CMMB) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows bearish technical indicators, no significant positive catalysts, and weak financial performance. Additionally, there are no trading signals or recent news to support a strong buy decision.
The technical indicators for CMMB are bearish. The MACD is negative and expanding downward, the RSI is neutral but leaning toward oversold territory, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 1.863, with key support at 1.433 and resistance at 2.129.
NULL identified. There are no recent news events, trading signals, or significant trading trends from hedge funds or insiders.
The company's financial performance is weak, with a significant drop in net income (-36.79% YoY) and EPS (-100.00% YoY). The technical indicators are bearish, and there is no recent congress trading data or influential figure activity.
In Q4 2025, the company reported zero revenue growth (0.00% YoY), a net income decline of -36.79% YoY, and an EPS drop of -100.00% YoY. Gross margin remained unchanged at 0. The financials suggest poor growth trends.
No recent analyst rating or price target changes available.
